Pomanda estimates the enterprise value of OXFORD BIOCITECH HOLDINGS LIMITED at £28.5k based on a Turnover of £9.2k and 3.11x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OXFORD BIOCITECH HOLDINGS LIMITED at £0 based on an EBITDA of £-31.6k and a 6.06x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OXFORD BIOCITECH HOLDINGS LIMITED at £70.8m based on Net Assets of £42.1m and 1.68x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oxford Biocitech Holdings LimitedOverview
Oxford Biocitech Holdings Limited is a live company located in united kingdom, W1S 3DG with a Companies House number of 13929455. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in February 2022, it's largest shareholder is
life sciences (uk) holdings ii limited
with a 100% stake. Oxford Biocitech Holdings Limited is a startup,
micro sized company, Pomanda has estimated its turnover at
£9.2k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Oxford Biocitech Holdings Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
2 Strong
2 Regular
4 Weak
Size
annual sales of £9.2k, make it smaller than the average company (£1.1m)
£9.2k - Oxford Biocitech Holdings Limited
£1.1m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Oxford Biocitech Holdings Limited
- - Industry AVG
Production
with a gross margin of 71%, this company has a comparable cost of product (71%)
71% - Oxford Biocitech Holdings Limited
71% - Industry AVG
Profitability
an operating margin of -345.6% make it less profitable than the average company (21.5%)
-345.6% - Oxford Biocitech Holdings Limited
21.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (4)
1 - Oxford Biocitech Holdings Limited
4 - Industry AVG
Pay Structure
on an average salary of £33.2k, the company has an equivalent pay structure (£33.2k)
£33.2k - Oxford Biocitech Holdings Limited
£33.2k - Industry AVG
Efficiency
resulting in sales per employee of £9.2k, this is less efficient (£202.7k)
£9.2k - Oxford Biocitech Holdings Limited
£202.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford Biocitech Holdings Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford Biocitech Holdings Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford Biocitech Holdings Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 92 weeks, this is more cash available to meet short term requirements (10 weeks)
92 weeks - Oxford Biocitech Holdings Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0%, this is a lower level of debt than the average (71.6%)
0% - Oxford Biocitech Holdings Limited
71.6% - Industry AVG
OXFORD BIOCITECH HOLDINGS LIMITED financials
EXPORT
Oxford Biocitech Holdings Limited's latest turnover from December 2023 is £9.2 thousand and the company has net assets of £42.1 million. According to their latest financial statements, we estimate that Oxford Biocitech Holdings Limited has 1 employee and maintains cash reserves of £21.7 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Turnover
9,157
Other Income Or Grants
Cost Of Sales
2,654
Gross Profit
6,503
Admin Expenses
38,150
9,385
Operating Profit
-31,647
-9,385
Interest Payable
Interest Receivable
Pre-Tax Profit
-31,077
-9,385
Tax
Profit After Tax
-31,077
-9,385
Dividends Paid
Retained Profit
-31,077
-9,385
Employee Costs
33,165
Number Of Employees
1
1
EBITDA*
-31,647
-9,385
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Tangible Assets
42,049,784
42,049,784
Intangible Assets
Investments & Other
42,049,784
42,049,784
Debtors (Due After 1 year)
Total Fixed Assets
42,049,784
42,049,784
Stock & work in progress
Trade Debtors
Group Debtors
1,000
1,000
Misc Debtors
Cash
21,729
misc current assets
total current assets
22,729
1,000
total assets
42,072,513
42,050,784
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
12,191
9,385
total current liabilities
12,191
9,385
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
12,191
9,385
net assets
42,060,322
42,041,399
total shareholders funds
42,060,322
42,041,399
Dec 2023
Dec 2022
Operating Activities
Operating Profit
-31,647
-9,385
Depreciation
Amortisation
Tax
Stock
Debtors
1,000
Creditors
Accruals and Deferred Income
2,806
9,385
Deferred Taxes & Provisions
Cash flow from operations
-28,841
-1,000
Investing Activities
capital expenditure
-42,049,784
Change in Investments
42,049,784
cash flow from investments
-84,099,568
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
50,000
42,050,784
interest
cash flow from financing
50,000
42,050,784
cash and cash equivalents
cash
21,729
overdraft
change in cash
21,729
oxford biocitech holdings limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for oxford biocitech holdings limited. Get real-time insights into oxford biocitech holdings limited's credit score, group structure and payment trends.
Perform a competitor analysis for oxford biocitech holdings limited by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other micro companies, companies in W1S area or any other competitors across 12 key performance metrics.
oxford biocitech holdings limited Ownership
OXFORD BIOCITECH HOLDINGS LIMITED group structure
Oxford Biocitech Holdings Limited has no subsidiary companies.
The sole shareholder of Oxford Biocitech Holdings Limited is Life Sciences (Uk) Holdings Ii Limited.
life sciences (uk) holdings ii limited
100%
oxford biocitech holdings limited directors
Oxford Biocitech Holdings Limited currently has 2 directors.
The longest serving directors include
Mr Robin Everall (Oct 2022) and
Mr Jay Drexler (Dec 2024).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oxford biocitech holdings limited.
oxford biocitech holdings limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OXFORD BIOCITECH HOLDINGS LIMITED. This can take several minutes, an email will notify you when this has completed.
oxford biocitech holdings limitedCompanies House Filings - See Documents
